Rupayan Kundu, MD (he/him/his)

Cleveland Clinic Foundation

Poster(s):

• P0913 - How Many Doses of Infliximab Should Be Used in Immune Checkpoint Inhibitor-Induced Colitis? – A Retrospective Study
  Sunday, October 27, 2024

  3:30 PM - 7:00 PM ET